ETAL3 ASAP (#592)
Laufzeit: 01.01.2016 - 31.12.2024
imported
Kurzfassung
Evaluation of the impact of remission induction chemotherapy prior to allogeneic stem cell transplantation in relapsed and poor-response patients with AML